| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis RB Jones, JW Cohen Tervaert, T Hauser, R Luqmani, MD Morgan, ... New England Journal of Medicine 363 (3), 211-220, 2010 | 1979 | 2010 |
| Meta-analysis: test performance of ultrasonography for giant-cell arteritis FB Karassa, MI Matsagas, WA Schmidt, JPA Ioannidis Annals of Internal Medicine 142 (5), 359-369, 2005 | 425 | 2005 |
| Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes JPA Ioannidis, SH Ralston, ST Bennett, ML Brandi, D Grinberg, ... Jama 292 (17), 2105-2114, 2004 | 410 | 2004 |
| Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta‐analysis FB Karassa, A Afeltra, A Ambrozic, DM Chang, F De Keyser, A Doria, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 255 | 2006 |
| Role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta‐analysis FB Karassa, TA Trikalinos, JPA Ioannidis Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 247 | 2002 |
| Large‐scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand E Evangelou, K Chapman, I Meulenbelt, FB Karassa, J Loughlin, A Carr, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 235 | 2009 |
| Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22 E Evangelou, AM Valdes, HJM Kerkhof, U Styrkarsdottir, YY Zhu, ... Annals of the rheumatic diseases 70 (2), 349-355, 2011 | 194 | 2011 |
| The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis FB Karassa, TA Trikalinos, JPA Ioannidis Kidney international 63 (4), 1475-1482, 2003 | 178 | 2003 |
| Risk factors for central nervous system involvement in systemic lupus erythematosus FB Karassa, JPA Ioannidis, G Touloumi, KA Boki, HM Moutsopoulos Qjm 93 (3), 169-174, 2000 | 153 | 2000 |
| Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus FB Karassa, JPA Ioannidis, KA Boki, G Touloumi, MI Argyropoulou, ... The American journal of medicine 109 (8), 628-634, 2000 | 134 | 2000 |
| Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients PG Vlachoyiannopoulos, FB Karassa, KX Karakostas, AA Drosos, ... Lupus 2 (5), 303-312, 1993 | 130 | 1993 |
| The role of FcγRIIA and IIIA polymorphisms in autoimmune diseases FB Karassa, TA Trikalinos, JPA Ioannidis Biomedicine & Pharmacotherapy 58 (5), 286-291, 2004 | 128 | 2004 |
| The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence JPA Ioannidis, FB Karassa BMJ 341, 2010 | 82 | 2010 |
| Role of the Fcγ receptor IIA polymorphism in the antiphospholipid syndrome: An international meta‐analysis FB Karassa, M Bijl, KA Davies, CGM Kallenberg, MA Khamashta, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2003 | 74 | 2003 |
| Suicide attempts in patients with systemic lupus erythematosus FB Karassa, M Magliano, DA Isenberg Annals of the rheumatic diseases 62 (1), 58-60, 2003 | 73 | 2003 |
| Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales JPA Ioannidis, FB Karassa, E Druyts, K Thorlund, EJ Mills Nature Reviews Rheumatology 9 (11), 665-673, 2013 | 60 | 2013 |
| Mortality in systemic sclerosis FB Karassa, JPA Ioannidis Clinical & Experimental Rheumatology 26 (5), S85, 2008 | 60 | 2008 |
| Meta-analysis of the association between low-affinityFcγ receptor gene polymorphisms and hematologic and autoimmune diseases TA Trikalinos, FB Karassa, JPA Ioannidis Blood, The Journal of the American Society of Hematology 98 (5), 1634-1636, 2001 | 48 | 2001 |
| Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus. FB Karassa, A Tatsioni, JPA Ioannidis The Journal of Rheumatology 30 (5), 979-984, 2003 | 43 | 2003 |
| Who is afraid of reviewers’ comments? Or, why anything can be published and anything can be cited JP Ioannidis, A Tatsioni, FB Karassa Eur J Clin Invest 40 (4), 285-7, 2010 | 37 | 2010 |
